n the carton after EXP. The expiry date refers to the last day of that month.
There are no special precautions for storage.
6. Contents of the pack and other information
What Vesicare contains
•The active substance is solifenacin succinate 5 mg or 10 mg
•The other ingredients are maize starch, lactose, hypromellose (E464), magnesium stearate, macrogol, talc, titanium dioxide (E171) and iron oxide (E172)
What Vesicare looks like and contents of the pack
Vesicare 5 mg tablets are round, light yellow tablets marked with the company logo and the code “150” on the same side.
Vesicare 10 mg tablets are round, light pink tablets marked with the company logo and the code “151” on the same side.
Vesicare tablets are supplied in blister packs of 3, 5, 10, 20, 30, 50, 60, 90 or 100 tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
Astellas Pharma Ltd.
2000 Hillswood Drive
Chertsey
Surrey
KT16 0RS
UK
Tel: +44 (0) 203 379 8700
Manufacturer:
Astellas Pharma Europe B.V.
Sylviusweg 62
2333 BE Leiden
The Netherlands
Tel: +31 71 5455745
This medicinal product is authorised in the Member States of the EEA under the following names:
Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Latvia, Lithuania, Luxemburg, Malta, Netherlands, Norway, Poland, Portugal, Sweden, Slovenia, Slovakia, Spain and United Kingdom: Vesicare
Italy: Vesiker
Germany: Vesikur
Ireland: Vesitirim |
